64 reports

  • RHEUMATOID ARTHRITIS

It causes chronic inflammation of any part or the entire gastrointestinal tract.

  • Arthritis
  • Cancer Immunotherapy
  • AbbVie Inc.
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd.

Valeant manufactures and markets a wide range of branded generic pharmaceuticals, OTC products, and medical devices, catering to applications related to dermatology, eye health, aesthetics, consumer products, gastrointestinal health, oral health, neurology, and other therapeutic areas.

  • Arthritis
  • Allergan plc
  • Anika Therapeutics, Inc.
  • Sanofi S.A.
  • Seikagaku Corporation

Excluded from this report are Crohn' s disease and ulcerative colitis, as they fall under the gastrointestinal disorders therapy area.

  • Arthritis
  • World
  • Market Size
  • Johnson & Johnson
  • Novartis AG
  • Market drivers

People with obesity, diabetes, hypertension, renal failure, cardiovascular diseases, gastrointestinal bleeding, depression, and trauma in joints due to repetitive movements are subject to high risk due to knee osteoarthritis.

  • Arthritis
  • Anika Therapeutics, Inc.
  • Ferring International Center S.A.
  • Sanofi S.A.
  • Seikagaku Corporation

Rheumatoid arthritis

4546 5000 3864
  • PREVALENCE OF SELECTED CO-MORBIDITIES REPORTED IN THE INTERNATIONAL COMORA STUDY, BY REGION, 2014
  • RHEUMATOID ARTHRITIS PATIENTS RECEIVING TRADITIONAL NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, BY COUNTRY AND SEVERITY (%)

Side effects include gastrointestinal bleeding, and increased blood pressure particularly in hypertensive patients (van Laar, 2012).

  • Arthritis
  • Europe
  • Japan
  • Pfizer Inc.
  • Roche Group

Pharmaceutical: The Pharmaceutical segment includes products in areas, such as anti-infective, antipsychotic, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, neurology, oncology, pain management, thrombosis and vaccines.

  • Arthritis
  • United States
  • Anika Therapeutics, Inc.
  • Sanofi S.A.
  • Zimmer Biomet Holdings, Inc.

gastrointestinal, anti-infectious (antibacterial, antiviral), cardiovascular, anti-cancer, immunomodulant, reproductive, neurological, urological, dermatological and pediatric agents.

  • Arthritis
  • China
  • Demand
  • Novartis AG
  • Pfizer Inc.
  • 18.2 Market Share Analysis 2014

NSAIDs adversely affect the gastrointestinal, renal, and cardiovascular systems when used for over the long term.

  • Arthritis
  • Abbott Laboratories, Inc.
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • Opportunities for research in osteoarthritis
  • Vendor landscape

DONULIDE IS NOT RECOMMENDED FOR PATIENTS WITH GASTROINTESTINAL BLEEDING, ULCER, AND HYPERSENSITIVITY.

  • Arthritis
  • World
  • Market Size
  • Novartis AG
  • Pfizer Inc.
  • Rheumatoid Arthritis, Therapeutics, Global, All Pipeline Products, Preclinical
  • 7 Appendix

Its main reported adverse effects are related to the gastrointestinal tract and the nervous system.

  • Arthritis
  • Therapy
  • World
  • Market Size
  • Remicade group

REFERENCE CODE GDHCER##-## | PUBLICATION DATE JANUARY 2017 RHEUMATOID ARTHRITIS - EPIDEMIOLOGY FORECAST TO 2025 Executive Summary Rheumatoid arthritis (RA) is an autoimmune disease characterized by inflammation of the joints, bone and cartilage erosion, and joint deformity.

  • Arthritis
  • Australia
  • Japan
  • United States
  • Forecast

gastrointestinal, anti-infectious (antibacterial, antiviral), cardiovascular, anti-cancer, immunomodulant, reproductive, neurological, urological, dermatological and pediatric agents.

  • Arthritis
  • China
  • Bayer AG
  • Novartis AG
  • Pfizer Inc.
  • 11.1 BIBLIOGRAPHY

SAFE PRESCRIBING OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS IN PATIENTS WITH OSTEOARTHRITIS - AN EXPERT CONSENSUS ADDRESSING BENEFITS AS WELL AS GASTROINTESTINAL AND CARDIOVASCULAR RISKS.

  • Arthritis
  • Japan
  • United States
  • Ampio Pharmaceuticals, Inc.
  • Pfizer Inc.
  • ANTISENSE RNAI OLIGONUCLEOTIDE FOR ARTHRITIS AND GASTROINTESTINAL DISORDERS - DRUG PROFILE
  • Arthritis
  • Therapy
  • Company
  • Product Initiative
  • Pfizer Inc.
  • SMALL MOLECULES TO INHIBIT RIP2 FOR POLYARTHRITIS, GASTROINTESTINAL DISORDERS AND RHEUMATOID ARTHRITIS - DRUG PROFILE
  • Arthritis
  • Monoclonal Antibody
  • Therapy
  • United States
  • Product Initiative
  • Arthritis
  • Healthcare
  • Pharmaceutical
  • Therapy
  • Cellular Biomedicine Group Inc.

Its pipeline products include BLU-##, for treatment resistant gastrointestinal stromal tumors; BLU-##, used in hepatocellular carcinoma; BLU-##, for ret-mutations, fusions, and predicted resistant mutants, rare genetic disease target, immunokinase targets, and others.

  • Arthritis
  • Therapy
  • United States
  • Product Initiative
  • Tolero Pharmaceuticals, Inc.
  • BARICITINIB - DRUG PROFILE

There were no cases of tuberculosis or gastrointestinal perforations.

  • Arthritis
  • Cancer
  • Pharmaceutical
  • Therapy
  • Incyte Corporation
  • SMALL MOLECULES TO INHIBIT RIP2 FOR POLYARTHRITIS, GASTROINTESTINAL DISORDERS AND RHEUMATOID ARTHRITIS - DRUG PROFILE
  • CHIRONWELLS GMBH
  • Arthritis
  • Monoclonal Antibody
  • Therapy
  • United States
  • Product Initiative

Theravance develops product candidates for various therapeutic areas such as infectious diseases, respiratory, cardiovascular and gastrointestinal.

  • Arthritis
  • Europe
  • United States
  • Product Initiative
  • Pfizer Inc.
  • DIMETHYL FUMARATE DR - DRUG PROFILE

Key GI symptoms, including nausea, vomiting, upper and lower abdominal pain and diarrhea, will be assessed using two patient-reported symptom rating scales: the Individual Gastrointestinal Symptom and Impact Scale (IGISIS) and the Global Gastrointestinal Symptom and Impact Scale (G

  • Arthritis
  • Cell Therapy
  • United States
  • Product Initiative
  • Anavex Life Sciences Corp.
  • Sep 06, 2016: Zynerba Pharmaceuticals Launches Phase 2 Clinical Trial of ZYN002 CBD Gel for Treatment of Osteoarthritis

There were no reports of somnolence or fatigue and a very low incidence of gastrointestinal events was observed.

  • Arthritis
  • Chronic Pain
  • United States
  • Company
  • Zynerba Pharmaceuticals, Inc.

The company' s products are used for the treatment of pain management, immunological diseases, and gastrointestinal disorders.

  • Arthritis
  • Autoimmune Disease
  • United States
  • Company
  • Product Initiative
  • BARICITINIB - DRUG PROFILE

No grade ## gastrointestinal adverse events were reported.

  • Arthritis
  • Blood Disease
  • United States
  • Product Initiative
  • Incyte Corporation
  • SMALL MOLECULES TO INHIBIT RIP2 FOR POLYARTHRITIS, GASTROINTESTINAL DISORDERS AND RHEUMATOID ARTHRITIS - DRUG PROFILE
  • RHEUMATOID ARTHRITIS - PIPELINE BY ONCODESIGN SA, H1 2017
  • Arthritis
  • Autoimmune Disease
  • Chronic Disease
  • Pathology
  • Pfizer Inc.

There were no gastrointestinal perforations, no cancers and no deaths reported during the study.

  • Arthritis
  • Pharmaceutical
  • Risky Behaviour
  • United States
  • Galapagos NV
  • PIPELINE BY GLAXOSMITHKLINE PLC, H2 2016

The company offers over-the-counter products for pain relief, oral health, nutrition, skin health and gastrointestinal disorders.

  • Arthritis
  • Pharmaceutical
  • Vaccine
  • World
  • Product Initiative

There were no cases of tuberculosis or gastrointestinal perforations.

  • Arthritis
  • Autoimmune Disease
  • Monoclonal Antibody
  • United States
  • Product Initiative

Report covers products from therapy areas Oncology, Ophthalmology, Gastrointestinal, Immunology, Genito Urinary System And Sex Hormones, Musculoskeletal Disorders, Toxicology, Cardiovascular, Central Nervous System, Dermatology, Hematological Disorders, Male Health, Metabolic Disorders and

  • Arthritis
  • Cardiovascular Drug
  • Hepatitis
  • Therapy
  • Can-Fite BioPharma Ltd.

Inflammatory bowel disease (IBD) is one of the most functional gastrointestinal disorders, caused due to abnormal immune response.

  • Arthritis
  • Autoimmune Disease
  • Diagnostics
  • World
  • Market Size